About The Conference
Allied academies pleasantly invite you to be a part of the ‘30thInternational Conference on Diabetes and Endocrinology’ on August 29-30, 2022 in Barcelona, Spain.
The milestone ofthe DiabetesCongress2022 will be the gathering of international experts and investigators to discuss the current situations and case studies, future innovations, and improvements on the topic of Diabetes and Endocrinology. All the selected sessions will have sub-sessions that make the event more understandable and all the vital information will be discussed more or less. Since this Diabetes Congress 2022 will take place across two days, the sessions will be focused on diabetes and endocrinology.
Significance and scope
The main objective of DiabetesCongress2022 is to spread the scientific and medicinal research and ideas about diabetes-related problems which include endocrine disorders, among the world to get better ideas about it. We promote research such as Diabetes Congress2022 to globalize the need for awareness about Diabetes conditions through international decisions and discussions which will create extraordinary solutions for the existing health problems related to Diabetes and endocrinology. Diabetes comes in a variety of types, increasing the requirement for treatment. Thus this conference Diabetes Congress 2022 will provide a great opportunity to deliberate all the important strategies and ongoing research to reduce diabetic patients all over the world.
Diabetes and Endocrinology are broad areas, and people are concentrating on developing new ideas and improving present approaches to improve diabetes treatments. This is a great opportunity to form a worldwide alliance of outstanding individuals from many nations who are specialists in diabetes legislation and to debate your research and inventions with bright minds in breakout sessions.
Diabetes Congress 2022 will have experts from different fields, doctors, dieticians, nurses, physicians, pharmacists, academic researchers, and other healthcare professionals. They talk about diabetes conditions, including the complications, effects, and precautions that come with them. Also discussed are modern technologies that aid in the reduction of diabetes complications in humans.
• Keynote speakers and Session speakers
• Young Research Forum (YRF)
• The platform and arrangements organise symposiums and workshops
• Research findings and proposals
• Exhibition of innovative products and devices related to the Diabetes Congress 2022
Diabetes & Metabolism Faculty | Diabetologist | Gynaecologists | Podiatrists | Medicare Associations | Healthcare Associations | Diabetes & MetabolismResearchers | Business Entrepreneur | Physicians | Ophthalmologists | Medical Colleges | Academic Researchers | Neurologists | Endocrinology Societies &Associations | Endocrinologists | Diabetes Societies &Associations | Nutritionists | Manufacturing Medical Device Companies | Oncologist | Training Institutes | Pharmaceutical Companies.
The 30th International Conference on Diabetes and Endocrinology will be held in Barcelona, Spain on August 29-30, 2022. Diabetes Congress 2022 aspires to bring together all of the world's leading scientists, researchers, doctors, medical professionals, pharmaceutical companies, and healthcare providers on the subject of diabetes and endocrinology. The conference's theme is "Enhancing Innovations in Diabetes and Endocrinology", implying that it will serve as a venue for investigating modernism in the field of diabetes. The leading advancements in diabetes and endocrinology will be discussed at this conference as treatment insights. This conference will provide attendees from colleges and institutions with an excellent opportunity to network with scientists, researchers, and promoters.
Join us in Barcelona, Spain for the Diabetes and Endocrinology Conference!
Session 1 - Diabetes typesand complications:
Diabetes mellitus,often known as blood sugar, is characterised by high glucose levels in theblood. Diabetes is a serious health problem that predominantly affects infectedpeople. Diabetes complications include vision loss, kidney disease, nervedamage, and stroke. Diabetes is without a doubt the greatest challengingmedical issue of the twenty-first century. The complications ofdiabetes are the topic of this session.
1. Skin conditions
2. Eye damage (retinopathy).
4. Alzheimer's disease
6. Cardiovascular disease
7. Type1 Diabetes
8. Type2 Diabetes
Session 2- Pre-diabetes:
Pre-diabetes is a condition in which blood sugar levels are higherthan normal but not high enough to be diagnosed as type 2 diabetes. If not managed, it will almost certainly progress totype 2 diabetes within ten years. Pre-diabetes affects the vast majority ofpeople without any warning signs or symptoms. It is not impossible to progressfrom pre-diabetes to type 2 diabetes. It is possible to recover to anormal blood sugar level with lifestyle changes, weight loss, and medication.
1. Process for diagnosis
2. Risk factors and clinical sign
3. Pre-diabetes and lifestyle modification4. Factors associated withpre-diabetes in an HIV-positive patient
Due to the general rising prevalence of endocrine disorders, the globalmarket for endocrinology drugs is exploding.High cholesterol absorption, work stress, and weight gain are all factors thatwill wreak havoc on the endocrine system. During the period 2018-2022, theglobal endocrinology medicine market grew at a 6.48 percent annual pace. Unlesssignificant illnesses are addressed, the rise of the pharmaceutical sector willcontinue, leading to a life where we can't exist without drugs. The workshopwill cover all endocrine-related difficulties, with professionals sharing assetpoints for establishing a better strategy to address these challenges.
1. Cardiovascular disorders
2. Hormone changes and their effects
3. Testing of endocrine disorder
4. Types of endocrine disorder
5. Causes of endocrine disorder
It explains the cell science and structure of the hormones and their endocrine glands. Topics like bonemetabolism, thyroid-related disorders, and muscle metabolism are included incellular and molecular endocrinology research. The main aim of this discussionis to disperse the latest strategies and inventions within cellular and molecularendocrinology, the discussion adds DNA technologies.
1. Swellingand redness in the infected area
2. Disordersof the Osteoporosis and Osteopenia
3. Osteoporosis in Women
4. Socio andeconomic impact of Osteopenia
Type 1 Diabetes is thought to be caused by anautoimmune reaction that destroys the beta cells in the pancreas, which produceInsulin. Type 2 diabetesis primarily caused by two conditions that are intertwined: In muscle, fat, andliver cells, insulin resistance develops. These cells don't bring in enoughsugar because they don't work with Insulin in a typical way.The pancreas is unable to produce enough insulin to maintain blood sugarcontrol. Increased thirst, frequent urination, acute hunger, unexplained weightloss, and the presence of ketones in the urine are some of the indications andsymptoms of type 1 and type 2 diabetes.
Session-15: Prevention ofDiabetes
Type 2 diabetes, the most common form of thecondition, can be prevented by making lifestyle modifications. If you arecurrently overweight or obese, have high cholesterol, or have a family history ofdiabetes, you are at a higher risk of acquiring type 2 diabetes.Changes in one's lifestyle can help to avoid or delay the start of thecondition. Changing your lifestyle today can help you avoid major diabeticconsequences such as nerve, kidney, and heart damage in the future. It's nevertoo late to try something new.
• Be morephysically active.
• Eathealthy plant foods
• Eathealthy fats
• Choose ahealthy lifestyle above fad diets.
· Diabetes Treatment
· Stem CellTherapy
· Type1 Diabetes Beta Cell
· Stem Cell and Diabetes
Plant-based therapies that have been demonstrated to haveanti-diabetic characteristics in some investigations include:
1. Aloe vera
2. Bilberry extract
3. Bitter melon
Indeed, because certain herbs, vitamins, and supplements may interact with diabetes medications (including insulin) and increase their hypoglycaemic effects, it isfrequently argued that using natural therapies could cause dangerously lowblood sugars and increase the risk of other diabetes complications.
Session 18: Diabetes and cardiovascular Diseases
Diabetes mellitus exacerbates the mechanisms behind atherosclerosis and coronary artery disease. Unfortunately, treatment options focusing simply on good glycemic control with currently available medicines or procedures do not sufficiently modify these processes. Women with diabetes face a significantly higher risk of coronary artery disease than women of the same age who do not have diabetes. Actually, the disease is by far the most common cause of mortality in both diabetes patients. Regrettably, the improvement in survival following a heart attack in diabetic patients has been less than half that of the general population. The main goal of this conference is to draw attention to the importance of early detection and treatment of diabetes in order to prevent its complications.
1. Heart disease
3. Diagnosis methods for Heart Disease
Session 18: Endocrinologyand Metabolism
The endocrine issue is constantly startling due tothe information factors involved with the endocrine system, including a mixedimage of hyposecretion and hypersecretion. For example, most kinds ofhyperthyroidism are accompanied by an excess of thyroid hormone and adeficiency of thyroid animating hormone. Patients with multi-transfusedthalassemia major may experience significant endocrine issues as a result ofiron overload. Syndrome X is a term used toexplain the problems that arise in many patients with various types ofcardiovascular disease (CVD) and diabetes as a result of insulin resistance,hyperinsulinemia, and cell ionic abnormalities.
• Neuro Endocrinology
• Symptoms and Diagnosis
• Management of Metabolicsyndrome
Allied conference is one of the world’s remarkable Scientific Conference Organizers who have their individuality in all the spectrums of Science, Technology, and Business. A part of every conference series’ success specifically hangs on to how far it reaches the online community. Having an online audience is critical to making an international gathering a great success; be it research or academic or industrial.
Research personnel, Academicians, Research institutes, Industrialists, and students from the field of Diabetes, Endocrinology, and Metabolism are the key participants who show an intense desire in attending the Diabetes Congress 2022 put forth by Allied Academies. Our conferences based on Diabetes, Endocrinology, and Metabolic studies show a significantly large number of unique visitors and page views which proved to be a thriving success.
Components such as rising diabetes incidence, technological developments, and new product launches are driving the global diabetes market. Increased government policies assuming the use of diabetes management solutions and expanding medical tourism are two main reasons driving market expansion. Furthermore, rising government initiatives to raise diabetes awareness and leading companies' increased R&D expenditure are projected to drive market expansion. The global diabetes implementation market size is awaiting to reach USD 41.6 billion by 2027, registering a CAGR of 7.8% over the divine period, according to a new report.
Significance and scope:
The Diabetes Meeting will focus on a variety of topics, allowing for a larger number of people to attend. This meeting will provide an opportunity to discuss recent developments in the fields of diabetes and endocrinology. Diabetes meetings will bring together scholarly and modern callings, resulting in a broader understanding. We recognise that understanding the scientist's examination is less difficult and more accommodating than understanding diabetes.
- Diabetes affects an estimated 537 million adults aged 20 to 79.
- Type1 diabetes affects more than 1.2 million children and teenagers aged 0 to 19.
- By 2030, the overall number of diabetics is expected to reach 643 million, rising to 783 million by 2045.
- Diabetes caused 6.7 million deaths
- Diabetes caused at least USD 966 billion in health expenditure – 9% of total spending on adults
- Diabetes affects one out of every six live births (21 million) and 541 million individuals are at risk of having type 2 diabetes.
China, India, and the United States of America are expected to have the highest number of adults with diabetes in 2021, and this trend is expected to continue until 2030. Pakistan's diabetes population is expected to surpass that of the United States of America by 2045, propelling the country to third place.
Endocrine Testing Market Segmentation Analysis:
• North America (U.S., Canada, Mexico)
• The European Union (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific region (China, Japan India, Rest of APAC)
• The continent of South America (Brazil and Rest of South America)
• Africa and the Middle East (UAE, South Africa, Rest of MEA)
Fastest Growing Market:
· Endocrine Society
· American Association of Clinical Endocrinologists
· The American Association of Endocrine Surgeons
· Association of Program Directors in Endocrinology, Diabetes, and Metabolism
· Society for Endocrinology
· Brazilian Society of Surgical Endocrinology
· British Society for Paediatric Endocrinology and Diabetes
· European Society of Endocrinology
· International Society of Endocrinology
· Paediatric Endocrine Society